aleks Bookmarks

Managing Multiple Myeloma While Living Alone

http://www.myelomabeacon.com/headline/2012/05/22/p...

Excellent article by a myeloma patient who discusses what it's like to have myeloma when you don't have a caregiver immediately available to help with the many challenges of the disease.

multiple myeloma myeloma caregiving myeloma news

Genetic Mutations In Myelodysplastic Syndromes

http://www.mdsbeacon.com/news/2012/04/10/genetic-m...

Researchers from Washington University in St. Louis recently discovered that nearly all mutations in the bone marrow cells of patients who progressed from myelodysplastic syndromes to acute myeloid le...

myelodysplastic syndromes genetic mutations mds news

Revlimid Maintenance Therapy Benefits And Risks

http://www.myelomabeacon.com/news/2012/05/11/revli...

Very useful summary of the results from three important research papers that were just published about maintenance therapy with Revlimid (lenalidomide) for people with multiple myeloma

multiple myeloma myeloma myeloma news revlimid lenalidomide

Kyprolis

http://www.myelomabeacon.com/tag/kyprolis/

Kyprolis news and resources for multiple myeloma patients, caregivers, and others interested in Kyprolis and multiple myeloma.

multiple myeloma myeloma carfilzomib kyprolis

Exjade MDS Myelodysplastic Syndromes

http://www.mdsbeacon.com/news/2012/05/03/exjade-de...

Results from a European study demonstrate that Exjade, a treatment for excess iron, may improve blood cell counts and reduce the need for red blood cell transfusions in myelodysplastic syndromes patie...

exjade deferasirox myelodysplastic syndromes mds mds news

Stem Cell Transplantation In Elderly MDS Patients:...

http://www.mdsbeacon.com/news/2012/04/24/stem-cell...

Dr. Nikolaus Kroeger, a German myelodysplastic syndromes expert, recently published a review of previous research to assess whether stem cell trans­plantation is feasible in elderly patients with mye...

myelodysplastic syndromes mds stem cell transplants mds news

Questions And Answers FDA Approval Subcutaneous Ve...

http://www.myelomabeacon.com/news/2012/01/25/quest...

Review of topics of importance related to the decision by the FDA to approve subcutaneous Velcade (bortezomib).

multiple myeloma myeloma myeloma news velcade bortezomib

Belinostat Velcade Bortezomib Myelodysplastic Synd...

http://www.mdsbeacon.com/news/2012/01/24/velcade-b...

A combination of the drugs Velcade and belinostat may be active in patients with myelodysplastic syndromes, according to results of a small Phase 1 clinical trial.

myelodysplastic syndromes mds velcade belinostat bortezomib

Velcade Subcutaneous Approved by FDA

http://www.myelomabeacon.com/news/2012/01/23/beaco...

The FDA has approved subcutaneous administration of Velcade (bortezomib) when the drug is used to treat multiple myeloma patients and patients with mantle cell lymphoma.

multiple myeloma myeloma velcade bortezomib myeloma news multiple myeloma news

AR-67 Shows Limited Activity In Myelodysplastic Sy...

http://www.mdsbeacon.com/news/2012/01/06/investiga...

Results from a small Phase 2 clinical trial show that the investigational drug AR-67 is tolerable for myelodysplastic syndromes patients. However, the results also show that the drug has limited activ...

ar-67 myelodysplastic syndromes mds mds cancer mds news